Long-term Protective Changes in Adipose Tissue After Gastric Bypass

Area of Science:

• Metabolic Surgery
• Adipose Tissue Biology
• Endocrinology

Background:

• Bariatric surgery, such as Roux-en-Y gastric bypass (RYGB), often leads to significant weight loss and improvements in metabolic health.
• However, long-term weight regain can occur, raising questions about the durability of metabolic benefits, particularly protection against type 2 diabetes.

Purpose of the Study:

• To investigate the long-term effects of RYGB on adipose tissue function.
• To determine if improvements in adipose function contribute to the diabetes-protective effects observed after bariatric surgery, even in the presence of weight regain.

Main Methods:

• A longitudinal study of 49 obese women before and 2 and 5 years after RYGB.
• Comparison of 30 RYGB patients at 5 years with 30 matched control subjects.
• Analysis of subcutaneous abdominal adipose tissue biopsies for fat cell characteristics, lipolysis, adiponectin, and inflammatory markers.

Main Results:

• RYGB significantly improved insulin sensitivity (HOMA-IR), increased adiponectin, and reduced fat cell size and lipolysis by 2 years post-surgery.
• By 5 years, despite some weight regain, adipose tissue function remained more favorable than in controls, with improved insulin sensitivity and adiponectin levels.
• However, increased tumor necrosis factor-α secretion and fat cell number were observed at 5 years compared to 2 years, though still better than controls.

Conclusions:

• RYGB induces long-term improvements in adipose tissue phenotype and insulin sensitivity that surpass baseline and control states, despite potential weight regain.
• These sustained beneficial alterations in adipose function likely play a role in the diabetes-protective effects of bariatric surgery.